# Acumen Pharmaceuticals (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/acumen-pharmaceuticals-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 50 |
| Citations | 25,986 |
| City | Livermore |
| Country | United States |
| Description | Acumen Pharmaceuticals (United States) is a research organisation in Livermore, United States. OpenAlex records 105 works and 25,986 citations for it. 2 researchers list it as their most recent affiliation. |
| Homepage | http://www.acumenpharm.com/ |
| OpenAlex ID | https://openalex.org/I4210160595 |
| Region | California |
| Researchers | 2 |
| ROR ID | https://ror.org/05pvq8q22 |
| Type | company |
| Works | 105 |

## University papers

- [Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease](https://scholariq.org/papers/toward-defining-the-preclinical-stages-of-alzheimer-s-disease-recommendations/)
- [Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup](https://scholariq.org/papers/revised-criteria-for-diagnosis-and-staging-of-alzheimer-s-disease-alzheimer-s/)
- [Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease](https://scholariq.org/papers/phase-3-trials-of-solanezumab-for-mild-to-moderate-alzheimer-s-disease/)
- [Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease](https://scholariq.org/papers/trial-of-solanezumab-for-mild-dementia-due-to-alzheimer-s-disease/)
- [Amyloid beta oligomers induce impairment of neuronal insulin receptors](https://scholariq.org/papers/amyloid-beta-oligomers-induce-impairment-of-neuronal-insulin-receptors/)

## University researchers

- [Eric Siemers](https://scholariq.org/researchers/eric-siemers/)
- [Grant A. Krafft](https://scholariq.org/researchers/grant-a-krafft/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.